Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tenaya Therapeutics

Request full access

Dedicated to discovering and developing novel therapies for heart failures

San Francisco, United StatesFounded 2016Biotech & Life Sciences

About Tenaya Therapeutics

Tenaya Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering potentially curative therapies for heart disease. The company operates in the healthcare and biotechnology market, primarily serving patients suffering from various forms of heart disease. Tenaya's business model revolves around leveraging advanced scientific research and precision medicine to create innovative treatments that address the underlying causes of heart conditions. The company generates revenue through the development and commercialization of its therapeutic products, which are currently in various stages of preclinical and clinical development. Tenaya Therapeutics aims to transform the lives of individuals and families affected by heart disease by offering groundbreaking solutions that go beyond symptom management to target the root causes of the condition.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2021
Employees
96
Open positions
None listed
Dealroom signal
64.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Cardiology and cardiovascular, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITYOther financing Dec 2025 $0 — Undisclosed ↗
POST IPO EQUITYOther financing Mar 2025 $53M — Undisclosed ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Tenaya Therapeutics website traffic

Latest recorded traffic for Tenaya Therapeutics is 6.1K monthly website visits, down 17.6% over the last three months. Tenaya Therapeutics's team declined 10.3% over the past year.

Latest monthly visits6.1K 3-month web change-17.6% 1-year team growth-10.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tenaya Therapeutics in the San Francisco ecosystem

Live from Dealroom

The Tenaya Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later11 investors entered at this stage

Other known investors1 additional known investor

  • University of California, Berkeley
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.8%
🇨🇳 China1.2%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tenaya Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tenaya Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.